Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-24-065566

Options or other derivatives

  • SVP, General Counsel and Sec. acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Veness Adam M SVP, General Counsel and Sec. 2024-05-23 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/ownership.xml…